FDA Adverse Event Malfunction Summary report: N

BD PHOENIX¿ NMIC-311

MDR report key: 20745571 · Received November 21, 2024

Report

Report Number
1119779-2024-00913
Event Type
Malfunction
Date Received
November 21, 2024
Date of Event
August 31, 2024
Report Date
December 11, 2024
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
LON
UDI-DI
30382904494521
PMA / PMN Number
SEE H11
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WERE MULTIPLE 510K NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR THE ADDITIONAL 510K IS AS FOLLOWS: G4. PMA / 510(K)#: K020322, K022129, K023444, K023634, K023858, K024153, K031530, K031699, K031912, K032299, K032567, K032655, K033362, K033560, K041384, K042932, K052269, K060214, K060217, K060257, K060444, K060447, K061327, K061355, K062207, K062944, K063301, K063486, K063573, K063811, K063824, K071623, K123404, K132674, K132909, K151320, K173252, K190905, K163637, K173523, K033458, AND K123266. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY THIS COMPLAINT IS FOR FALSE RESISTANCE TO CARBAPENEMS WHEN USING PHOENIX PANEL NMIC-311 (CATALOG NUMBER 449452) BATCH NUMBER 4192399. THE CUSTOMER DID NOT PROVIDE PANEL RETURNS BUT PROVIDED ISOLATES AND PHOENIX GENERATED LAB REPORTS FOR THE INVESTIGATION. THE LAB REPORTS SHOW KLEBSIELLA PNEUMONIAE AND PROTEUS MIRABILIS WITH VARIED CARBAPENEM MICS WHEN USING THE COMPLAINT BATCH. TO INVESTIGATE, RETENTION PANELS OF COMPLAINT BATCH 4192399 WERE INOCULATED WITH CUSTOMER RETURNED ISOLATES K. PNEUMONIAE D1, K. PNEUMONIAE D11, P. MIRABILIS C1 AND P. MIRABILIS C2 AND EVALUATED FOR CARBAPENEM MIC RESULTS. IN ADDITION, ONE CONTROL PANEL EACH FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE INOCULATED WITH CUSTOMER RETURNED ISOLATES K. PNEUMONIAE D1, K. PNEUMONIAE D11, P. MIRABILIS C1 AND P. MIRABILIS C2 AND EVALUATED FOR CARBAPENEM MIC RESULTS. ALL PANELS TESTED RETURNED THE EXPECTED MICS FOR CARBAPENEMS, THEREFORE, THIS COMPLAINT IS NOT CONFIRMED. THE BATCH HISTORY RECORD WAS SATISFACTORY AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED, AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. BD WILL CONTINUE TO MONITOR FOR TRENDS ASSOCIATED WITH THIS DEFECT. PLEASE CONTINUE TO COMMUNICATE ADDITIONAL CONCERNS.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-311 AN UNSPECIFIED NUMBER OF PATIENT ISOLATES HAD HIGH MICS FOR CARBAPENEMS. THE USER NOTED THAT SPECIFIC DRUGS LIKE, ERTAPENEM AND MEROPENEM, ARE RESISTANT BUT ARE NOT WITH REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-311 AN UNSPECIFIED NUMBER OF PATIENT ISOLATES HAD HIGH MICS FOR CARBAPENEMS. THE USER NOTED THAT SPECIFIC DRUGS LIKE, ERTAPENEM AND MEROPENEM, ARE RESISTANT BUT ARE NOT WITH REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2430512 BD PHOENIX¿ NMIC-311 SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION LON BECTON DICKINSON & CO. (SPARKS) 4192399 30382904494521

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown